German Chamomile (Matricaria recutita) has a long history of traditional use for various skin conditions, including eczema (atopic dermatitis). More recently, its use has been supported by scientific studies, particularly in the form of topical applications. The active constituents of German chamomile, such as chamazulene and α-bisabolol, exhibit anti-inflammatory, antiphlogistic, and mild antimicrobial properties.

Several clinical trials and studies have investigated the efficacy of chamomile preparations for eczema. For example, a double-blind randomized study published in 1987 compared a chamomile cream to hydrocortisone and placebo in patients with eczema, finding that the chamomile cream had a moderate effect and was somewhat comparable to low-potency hydrocortisone cream. Additional in vitro and animal studies have demonstrated that chamomile extracts can reduce inflammation and promote skin healing.

However, while there is scientific support for chamomile’s efficacy in reducing symptoms such as itching and inflammation in mild to moderate eczema, the overall quality of evidence is moderate due to limitations in study design, small sample sizes, and variability in product formulations. Chamomile is generally considered safe for topical use, but allergic reactions are possible, especially in individuals sensitive to plants in the Asteraceae family.

In summary, German chamomile is justified for use in eczema management based on both traditional and moderate scientific evidence, primarily as a supportive, adjunctive treatment rather than a replacement for conventional therapies.